Impact of uncontrolled vs controlled rate freeze-thaw technologies on process performance and product quality

PDA Journal of Pharmaceutical Science and Technology

Volumn 64, Issue 4, 2010, Pages 290-298

  Padala, Chakradhar ^a   Jameel, Feroz ^a   Rathore, Nitin ^a   Gupta, Kapil ^a   Sethuraman, Ananth ^a  

^a AMGEN INC   (United States)

Author keywords

Carboys; Celsius Pak; Controlled rate freezing; Cryoconcentration; CryoVessel; Freeze thaw; Protein

Indexed keywords

HYBRID PROTEIN; PROTEIN;

ARTICLE; BIOTECHNOLOGY; CONTROLLED STUDY; FREEZE THAWING; PHYSICAL CHEMISTRY; PROTEIN LOCALIZATION; TEMPERATURE MEASUREMENT; BACTERIAL COUNT; CRYOPRESERVATION; FREEZE DRYING; FREEZING; TECHNOLOGY;

COLONY COUNT, MICROBIAL; CRYOPRESERVATION; FREEZE DRYING; FREEZING; PROTEINS; TECHNOLOGY;

EID: 78149334415     PISSN: 10797440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Webb, S. D.; Webb, J. N.; Hughes, T. G.; Sesin, D. F.; Kincaid, A. C. Freezing biopharmaceutical using common techniques - and the magnitude of bulk scale freeze-concentration. Biopharm 2002, 15 (5), 22-34.
2. Lashmar, U. T.; Vnanderburgh, M.; Little, S. J. Bulk freeze-thaw of macromolecules: effect of cryoconcentration on their formulation and stability. BioProcess Int. 2007, 5 (6), 44-54.
3. Glaser, V. Addressing stability of biological drugs. Gen. Eng. Biotechnol. News 2005, 25 (6).
4. Pikal-Cleland, K. A.; Cleland, J. L.; Anchordoquy, T. J.; Carpenter, J. F. Effect of glycine on pH changes and protein stability during freeze-thawing in phosphate buffer systems. J. Pharm. Sci. 2002, 91 (9), 1969-1979.
5. Strambini, G. B.; Gabellieri, E. Protein in frozen solutions: evidence of ice-induced partial unfolding. Biophys. J. 1996, 70 (2), 971-976.
6. Cao, E.; Chen, Y.; Cui, Z.; Foster, P. R. Effect of freezing and thawing rates on denaturation of protein in aqueous solutions. Biotechnol. Bioeng. 2003, 82 (6), 684-690.
7. Hsu, C. C.; Nguyen, H. M.; Yeung, D. A.; Brooks, D. A.; Koe, G. S.; Bewley, T. A.; Pearlman, R. Surface denaturation at solid-void interface - a possible pathway by which opalescent particulates form during the storage of lyophilized tissue-type plasminogen activator at high temperatures. Pharm. Res. 1995, 12 (1), 69-77.
8. Privalov P. L. Cold denaturation of proteins. Crit. Rev. Biochem. Mol. Biol. 1990, 25 (4), 281-305.
9. Jayachithra, K.; Kumar, T. K. S.; Lu, T.; Yu, C.; Chin D. Cold instability of aponeocarzinostatin and its stabilization by labile chromophore. Biophys. J. 2005, 88 (6), 4252-4261.
10. Antonino, L. C.; Kautz, R. A.; Nakano, T.; Fox, R. O.; Fink, A. L. Cold denaturation and 2H2O stabilization of a staphylococcal nuclease mutant. Proc. Natl. Acad. Sci. 1991, 88 (17), 7715-7718.
11. Wilkins, J.; Sesin, D.; Wisniewski, R. Large-scale cryopreservation of bio-therapeutic products. Innov. Pharm. Technol. 2001, 8, 174.
12. Voute, N.; Dooley, T.; Peron, G.; Lee, E. Disposable technology for controlled freeze-thaw. BioProcess Int. 2004, Supplement, 40-43.